BRAF mutations in papillary carcinomas of the thyroid. - Wikidata - awgldk - TriplyDB

BRAF mutations in papillary carcinomas of the thyroid.

BRAF mutations in papillary carcinomas of the thyroid.

http://www.wikidata.org/entity/Q44595824

about

UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas Polymorphisms of the BRAF gene predispose males to malignant melanoma Inhibition of Mutated, Activated BRAF in Metastatic Melanoma BRAF V600E mutation in prognostication of papillary thyroid cancer (PTC) recurrence RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors TSH signalling and cancer.Impact of molecular testing in the diagnosis of thyroid fine needle aspiration cytology: data from mainland China.Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.Learning rule sets from survival data.Mutation analysis of key genes in RAS/RAF and PI3K/PTEN pathways in Chinese patients with hepatocellular carcinoma.Prognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital.Update on anaplastic thyroid carcinoma: morphological, molecular, and genetic features of the most aggressive thyroid cancer.Impact of NRAS Mutations on the Diagnosis of Follicular Neoplasm of the Thyroid.Molecular pathogenesis and mechanisms of thyroid cancer Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules Common SNP in pre-miR-146a decreases mature miR expression and predisposes to papillary thyroid carcinoma Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review.Differentiated thyroid cancer: focus on emerging treatments for radioactive iodine-refractory patients.Recurrent papillary thyroid carcinoma with pleural metastasis diagnosed by effusion cytology: a report of cases with clinicopathologic correlation.Our approach to follicular-patterned lesions of the thyroid Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.RET polymorphisms might be the risk factors for thyroid cancer.Identification of a rare 3 bp BRAF gene deletion in a thyroid nodule by mutant enrichment with 3'-modified oligonucleotides polymerase chain reaction.Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma.Mouse models of follicular and papillary thyroid cancer progression.Detection of BRAF V600E activating mutation in papillary thyroid carcinoma using PCR with allele-specific fluorescent probe melting curve analysis.BRAF(V600E) mutation is highly prevalent in thyroid carcinomas in the young population in Fukushima: a different oncogenic profile from Chernobyl Detection of BRAF(V600E) Mutations in Papillary Thyroid Carcinomas by Peptide Nucleic Acid Clamp Real-Time PCR: A Comparison with Direct Sequencing Genetic considerations in thyroid cancer.Wild-Type KRAS and BRAF Could Predict Response to Cetuximab in Chinese Colorectal Cancer Patients Clinical utility of TERT promoter mutations and ALK rearrangement in thyroid cancer patients with a high prevalence of the BRAF V600E mutation.BRAF V600E mutation in anaplastic thyroid carcinomas and their accompanying differentiated carcinomas Papillary carcinoma of the thyroid: methylation is not involved in the regulation of MET expression.BRAF inhibitors in clinical oncology.Recent progress of genome study for anaplastic thyroid cancer.Essential genes in thyroid cancers: focus on fascin.Phase II trial of sorafenib in metastatic thyroid cancer Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.Clinicopathological and molecular histochemical review of skull base metastasis from differentiated thyroid carcinoma Molecular pathology of thyroid cancer: diagnostic and clinical implications.

P2860

Q24651210-C520145E-A0E7-4951-B166-0B5E3A0FA00D Q24806439-5ACF0C8F-5C5C-4B97-908D-3A5785664783 Q27860458-4B07F392-20FC-4C95-BA4D-A54724865525 Q28075975-4236E3C7-1300-40D0-AECF-594E9FDB55B8 Q28258450-AE13E2A6-5834-47AB-8DF2-70BBC496F968 Q30364765-FD12F749-3F5C-48DD-A9C4-1D593B9A502D Q30769508-C2262E57-21C7-4092-ADD8-31AF706D8F15 Q33691759-32448E15-3168-4B35-89C2-C19EB1397337 Q33743432-55D01A95-85E5-480B-BF89-93E39548E556 Q33968053-AB0C7F0C-74EC-4B9A-AA6B-2A380E8BB4B4 Q34041618-53BE1F02-5AE7-4ADE-A24A-E90F60CD5195 Q34152070-AAC8403D-20BA-4DB5-B26C-A27A8132F37D Q34183230-6312E03F-AEB6-4EDC-B6A1-832B626B7BBA Q34329018-3C81D8B8-8ED2-4CA2-B512-F78D3B7B19FF Q34690607-55FD565B-81C9-4C9D-8780-E3CCE9AB625B Q34778280-F0B633CF-C598-4288-8943-F75935F41DFC Q35051065-85C21ECE-BB4D-442F-98F7-E1CB9F902BF7 Q35057314-868A9F60-0806-4AFE-B489-88DB68459EB5 Q35114388-07E3280D-8E57-44A6-A655-71F0D1A732B0 Q35770516-36AD6232-ED10-4F6E-87D6-A5C1C4881270 Q35832157-B74A2ED9-F570-485B-98A3-9BD35A1B7CCE Q35854406-FA320E01-A725-4896-95A9-70D5840887FE Q35919865-8D3C616A-EBAF-4D92-8C3B-33182DF42000 Q35920853-47328D38-6AC9-4548-8A29-A163EAE1EC48 Q35971896-8469C9C7-383D-470F-9750-EEFD8928D400 Q36172170-A4946FD8-4837-4195-A489-CFC35F6532C6 Q36301491-6ECDBF92-2FA1-4F06-8D5C-F2265C36E46C Q36343380-4A3326F6-5E57-4B74-A306-4047D6248170 Q36493223-9F5A3EE7-B2B0-4599-BB88-612E1BA31E1F Q36551097-758CB788-8ED2-4A6B-8FEB-B6BE6A9C8003 Q36560914-F4620AE1-A282-4DCE-9EC1-CBF248BA7ED7 Q36609544-30922A79-B85A-4F4D-A822-50518200E421 Q36626127-FECB04C7-D618-463F-B92B-C72E01E450BB Q36747050-A74183F9-3AD8-4CB7-BFD7-01BE4CE6D896 Q36992782-639B18A3-8731-4E55-AF9F-166B793F9F45 Q37071818-04150A68-CC21-412E-A905-293C8C527520 Q37158278-AD68022A-FC6D-4641-A27F-6A7C5DD9320A Q37216703-FA465403-9414-496F-8670-609D2276DA93 Q37269653-FD9E2184-7ECE-4E4F-84A2-9D97A9E90FB8 Q37337504-9E725117-6D36-4F57-B291-78F8391F33E0

P2860

BRAF mutations in papillary carcinomas of the thyroid.

http://www.wikidata.org/entity/Q44595824

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

BRAF mutations in papillary carcinomas of the thyroid.

@en

BRAF mutations in papillary carcinomas of the thyroid.

@nl

type

label

BRAF mutations in papillary carcinomas of the thyroid.

@en

BRAF mutations in papillary carcinomas of the thyroid.

@nl

prefLabel

BRAF mutations in papillary carcinomas of the thyroid.

@en

BRAF mutations in papillary carcinomas of the thyroid.

@nl

P1433

Q44595824-050B1911-EA34-4821-9F78-E08D52E2DF40

P1476

Q44595824-67F02110-9D38-4048-B17F-6116C132DE21

P2093

Q44595824-0FB8B853-B9E0-41AB-B397-CE5F96999749

Q44595824-1A8D2B11-C3A8-4C1C-8B10-C05D5D6B9320

Q44595824-598A8DDD-8018-48CE-9F86-2A93643CA360

Q44595824-687D1466-0F1A-4FD7-AE69-26BC2EB5F63D

Q44595824-7AB1169F-BE25-4501-9359-EF31AD8E411B

Q44595824-7B76CAF0-71D1-4BCF-B3B9-C905EB281575

Q44595824-7BD60EEE-1397-4106-BD00-7B094C7C2D28

Q44595824-8A5C41BC-29AB-44CF-8CDD-6BC9A9883302

Q44595824-91E04ACC-5921-410C-87EC-809469325717

P2860

Q44595824-0455B62C-DDE5-4D21-A95D-8F870EFC9E7A

Q44595824-20A228DE-1EE7-47D4-B739-6AA306801D30

Q44595824-2799219A-E2AA-43C6-B316-9F1AB33D2E7E

Q44595824-7465A6D0-DB9E-41AE-84A1-F9FB88F5705C

Q44595824-83DA6BFE-D3EA-4B71-A90E-2EABD80C5B27

Q44595824-A4DE8498-E272-4716-AE33-6FB7455818F2

Q44595824-F2B4C5A0-47F4-4FA3-91CD-0F61AC1B87E9

P2888

Q44595824-349F164E-3981-4858-91EB-914F51CB2797

P304

Q44595824-9A1B7F6D-3BDD-4361-8925-49B99F11EFA2

P31

Q44595824-4803CB49-8EBC-42B2-8935-154B724DE6EC

P356

Q44595824-F3DD0D44-0FCB-4635-A5AB-5623B77FD5D7

P407

Q44595824-9FCD197F-2437-422A-A0CD-35F08A27C60D

P433

Q44595824-C15D24F6-DB52-438A-B3D8-3C377A7F351C

P478

Q44595824-545B9846-7359-48AC-ADE8-3D1D264C23CE

P577

Q44595824-3E631E2B-AE77-4B1C-92D2-FBC5C673EB7E

P5875

Q44595824-C2C880D7-3659-464A-89A8-E0D8221D7F07

P698

Q44595824-2C015FFE-3619-45A3-9BFF-ACF55E7C0363

P356

P1433

P1476

BRAF mutations in papillary carcinomas of the thyroid.

@en

P2093

Koichi Hagiwara

http://www.w3.org/2001/XMLSchema#string

Koji Sekikawa

http://www.w3.org/2001/XMLSchema#string

Miyuki Mashiko

http://www.w3.org/2001/XMLSchema#string

Seiichi Takenoshita

http://www.w3.org/2001/XMLSchema#string

Shinichi Suzuki

http://www.w3.org/2001/XMLSchema#string

Tohru Ohtake

http://www.w3.org/2001/XMLSchema#string

Toshihiko Fukushima

http://www.w3.org/2001/XMLSchema#string

Yoshiyuki Endo

http://www.w3.org/2001/XMLSchema#string

Yuji Takebayashi

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations of the BRAF gene in human cancer

The regulation of normal melanocyte proliferation.

Molecular genetics of thyroid tumors and surgical decision-making.

Development of anticancer drugs targeting the MAP kinase pathway.

Ras mediates the cAMP-dependent activation of extracellular signal-regulated kinases (ERKs) in melanocytes

Oncogene profile of papillary thyroid carcinoma

Selective activation of ras oncogenes in follicular and undifferentiated thyroid carcinomas

P2888

P304

6455-6457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1206739

http://www.w3.org/2001/XMLSchema#string

P407

P433

41

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9080534

http://www.w3.org/2001/XMLSchema#string

P698

14508525

http://www.w3.org/2001/XMLSchema#string